The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law A closer look at the unapproved peptide injections promoted by influencers and celebrities king5.com